IQV

IQVIA Holdings Inc

267.33

Oct 30 • 3:59 PM ET -7.73 (-2.81%)

266.74

Aftermarket • 7:32 PM ET -0.59 (-0.22%)

Healthcare Diagnostics & Research USA Large NYSE

Oct 28, 11:03 AMSix post-earnings target hikes lift IQVIA 3.5% as Q3 beat gains traction

Peers: ICLR MEDP TMO LH FTRE CRL VEEV DHR TEM CERT

| Held by: VTI VOO VO IVV SPY VTV XLV VOE RSP IWR

Scroll to Statements

Index	S&P 500
Market Cap	44.06B
Enterprise Value	58.08B
Income	1.39B
Sales	17.32B
Book/sh	40.41
Cash/sh	14.70
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	0.00%
Employees	93000
IPO	May 09, 2013

P/E	32.48
Forward P/E	18.85
PEG	1.85
P/S	2.54
P/B	6.62
P/C	18.19
P/FCF	21.19
EV/EBITDA	16.07
EV/Sales	3.35
Quick Ratio	0.83
Current Ratio	0.83
Debt/Eq	2.45
LT Debt/Eq	2.26
Option/Short	Yes / Yes

EPS (ttm)	8.23
EPS next Y	14.18
EPS next Q	3.59
EPS this Y	8.73%
EPS next Y	9.44%
EPS next 5Y	10.17%
EPS past 3/5Y	11.05% 40.52%
Sales past 3/5Y	4.18% 7.50%
EPS Y/Y TTM	13.11%
Sales Y/Y TTM	8.88%
EPS Q/Q	8.71%
Sales Q/Q	8.00%
Earnings	Oct 27 BMO
EPS/Sales Surpr.	2.47% 1.44%

Insider Own	1.00%
Insider Trans	-6.89%
Inst Own	101.80%
Inst Trans	-2.10%
ROA	4.71%
ROE	21.75%
ROIC	6.42%
Gross Margin	26.05%
Oper. Margin	13.84%
Profit Margin	8.05%
SMA20	-0.26%
SMA50	0.47%
SMA200	27.59%
Trades

Shs Outstand	164.80M
Shs Float	163.15M
Short Float	1.83%
Short Ratio	2.11
Short Interest	2.99M
52W High	284.50 -6.04%
52W Low	154.50 73.03%
Volatility	4.51% 3.38%
ATR (14)	9.07
RSI (14)	49.00
Beta	1.17
Rel Volume	0.81
Avg Volume	1.42M
Volume	1,150,295

Perf Week	-4.31%
Perf Month	2.54%
Perf Quarter	14.56%
Perf Half Y	69.44%
Perf YTD	18.60%
Perf Year	23.50%
Perf 3Y	50.90%
Perf 5Y	2.26%
Perf 10Y	272.48%
Recom	1.42
Target Price	314.47
Prev Close	275.06
Price	267.33
Change %	-2.81%

Consensus

Strong Buy

Avg. Price Target

$314.47

Implied Upside

+17.6%

Analysts14incl. previous ratings

Rating Distribution12 Buy · 2 Hold · 0 Sell

Date	Action	Analyst	Rating Change	Price Target Change	Implied Upside
Sep 30, 2026	Resumed	UUBS	Buy	$345	+29.1%
Jun 17, 2026	Downgrade	MMorgan Stanley	Overweight → Equal-Weight	$200	-25.2%
Mar 09, 2026	Upgrade	TTD Cowen	Hold → Buy	$213	-20.3%
Mar 06, 2026	Upgrade	BBarclays	Equal Weight → Overweight	$210	-21.4%
Mar 03, 2026	Initiated	RRBC Capital Mkts	Outperform	$221	-17.3%
Dec 02, 2025	Resumed	MMorgan Stanley	Overweight	$265	-0.9%
Nov 13, 2025	Initiated	BBMO Capital Markets	Outperform	$260	-2.7%
Nov 03, 2025	Downgrade	TTD Cowen	Buy → Hold	$215	-19.6%
Oct 29, 2025	Upgrade	RRobert W. Baird	Neutral → Outperform	$258	-3.5%
Oct 09, 2025	Upgrade	HHSBC Securities	Hold → Buy	$235	-12.1%
Sep 09, 2025	Upgrade	JJefferies	Hold → Buy	$225	-15.8%
Apr 25, 2025	Downgrade	HHSBC Securities	Buy → Hold	$160	-40.1%
Apr 10, 2025	Downgrade	BBarclays	Overweight → Equal Weight	$170	-36.4%
Feb 03, 2025	Downgrade	BBTIG Research	Buy → Neutral
Dec 20, 2024	Initiated	SStephens	Overweight	$250	-6.5%
Oct 14, 2024	Initiated	RRedburn Atlantic	Buy
Sep 04, 2024	Initiated	RRBC Capital Mkts	Outperform	$275	+2.9%
Jul 24, 2024	Downgrade	JJefferies	Buy → Hold	$266 → $242	-9.5%
Jun 06, 2024	Initiated	GGoldman	Buy	$270	+1.0%
Feb 26, 2024	Initiated	LLeerink Partners	Outperform	$290	+8.5%

Oct-27-26 11:12AM	IQVIA Tops Every Line And Raises Guidance Again As Clinical Bookings Surge, But Commercial Slowdown And Backlog Cleanup Temper The Beat (Earnings Whispers)
07:52AM	IQVIA Holdings Boosts FY26 Outlook - Update (RTT News)
07:15AM	IQVIA: Q3 Earnings Snapshot (Associated Press)
07:00AM	IQVIA Reports Third-Quarter 2026 Results (Business Wire)
Oct-13-26 07:03AM	IQVIA Selects Veeva Clinical Operations Applications (PR Newswire)
10:19AM	Loading…
Oct-09-26 10:19AM	Could You Have Seen The Run In Tempus AI Stock Coming? (Trefis)
Oct-07-26 04:15PM	IQVIA Launches IQVIA Life Science Models to Help Life Sciences Companies Predict Clinical Trial Outcomes (Business Wire)
04:15PM	IQVIA Launches IQVIA Explorer to Help Life Sciences Companies Make Better Commercial Decisions (Business Wire)
Sep-29-26 04:15PM	IQVIA to Announce Third-Quarter 2026 Results on October 27, 2026 (Business Wire)
Sep-24-26 09:25AM	Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year? (Trefis)
Sep-09-26 05:13PM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:15AM	IQVIA Announces Offering of Senior Notes (Business Wire)
Sep-03-26 04:15PM	IQVIA's Predictive Clinical Development Provides Sponsors With Significant Efficiencies to Get Treatments to Market Faster (Business Wire)
Sep-02-26 12:24PM	Beyond The Cloud Giants: What Could Power NVIDIA Stock From Here? (Trefis)
Aug-27-26 08:19PM	Amgen Stock Signals Its Confidence. The Market Agrees. (Trefis)
04:15PM	Loading…
04:15PM	IQVIA Wins Multiple Industry Awards for AI and Technology Innovation Across Life Sciences and Healthcare (Business Wire)
Aug-24-26 02:23PM	What Is Really Moving Tempus AI Stock Right Now? (Trefis)
Aug-20-26 04:15PM	IQVIA's AI-Enabled Clinical Decision Support Tool Wins 2026 AI Breakthrough Award for Predictive Modeling Solution of the Year (Business Wire)
Aug-17-26 04:15PM	IQVIA Ranked No. 1 Pharmaceutical Technology Provider by Everest Group (Business Wire)
Aug-13-26 08:01AM	This Healthcare Services Stock Has 37% Upside (Barrons.com)
Aug-12-26 03:17PM	Amgen Stock And The Price Of A Promise (Trefis)
Aug-06-26 12:30PM	IQVIA, Medera Partner to Accelerate Development of Cardiac Gene Therapies (Exec Edge)
Aug-04-26 04:15PM	IQVIA and Medera to Advance Cardiac Gene Therapy and Human-Based Drug Discovery (Business Wire)
Jul-28-26 05:00PM	IQVIA Holdings Inc (IQV) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and AI-Driven ... (GuruFocus.com) +13.94%
12:44PM	This Healthcare Stock Is Today's Best in the S&P 500 (Barrons.com)
07:14AM	IQVIA: Q2 Earnings Snapshot (Associated Press)
07:00AM	IQVIA Reports Second-Quarter 2026 Results (Business Wire)
Jul-16-26 01:39PM	IQVIA's Dr. Cynthia Verst Testifies Before Congressional Subcommittee on More Efficient Path to Early Clinical Development in the United States (Business Wire)
Jul-08-26 04:15PM	IQVIA to Announce Second-Quarter 2026 Results on July 28, 2026 (Business Wire)
Jun-24-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +8.37%
09:47AM	Loading…
Jun-17-26 09:47AM	Lyft upgraded, Leidos downgraded: Wall Street's top analyst calls (The Fly)
09:13AM	Morgan Stanley favors Charles River Over IQVIA in CRO sector reset (Investing.com)
Jun-15-26 09:00AM	Wiley and IQVIA Release Cross-Sector Report on AI's Promise and Pressure Points Across Healthcare Value Chain (Business Wire)
Jun-04-26 10:51AM	IQVIA Announces Pricing of Senior Notes (Business Wire)
08:38AM	Is Veeva Stock Undervalued At $170? (Trefis)
Jun-03-26 02:53AM	IQVIA Announces Offering of Senior Notes (Business Wire)
May-28-26 04:30PM	IQVIA Holdings Inc. stock outperforms competitors on strong trading day (MarketWatch) +9.34%
May-26-26 04:15PM	IQVIA CEO to Speak at Jefferies Global Healthcare Conference (Business Wire)
May-13-26 04:30PM	IQVIA and Kexing Biopharm Expand Strategic Collaboration to Accelerate Global Biosimilar Development using AI-Enabled Capabilities (Business Wire)
May-07-26 05:15PM	IQVIA Board of Directors Approves $2 Billion Increase in Share Repurchase Authorization (Business Wire)
May-06-26 04:15PM	IQVIA CFO to Speak at Bank of America Health Care Conference 2026 (Business Wire)
May-05-26 07:14AM	IQVIA: Q1 Earnings Snapshot (Associated Press) +9.62%
07:00AM	IQVIA Reports First-Quarter 2026 Results (Business Wire)
Apr-24-26 11:46AM	Eli Lilly Stock Falls. Foundayo Is Fighting to Catch Novo's Wegovy Pill. (Barrons.com)
Apr-15-26 04:15PM	IQVIA to Announce First-Quarter 2026 Results on May 5, 2026 (Business Wire)
04:05PM	Lilly Stock Dips on FDA Request for More Foundayo Safety Data. Is the Market Reaction Overblown? (Barrons.com)
Mar-16-26 04:30PM	IQVIA Unveils IQVIA.ai, a Unified Agentic AI Platform Powered by NVIDIA to Improve Efficiency and Decision Making Across Life Sciences (Business Wire)
Mar-10-26 02:38PM	IQVIA Holdings Inc. (IQV) Advances Clinical Research and Data Capabilities to Drive Growth (Insider Monkey)
10:01AM	Is IQVIA Holdings Stock Underperforming the Nasdaq? (Barchart)
Mar-09-26 09:33AM	Netflix resumed, Starbucks downgraded: Wall Street's top analyst calls (The Fly)
Mar-04-26 10:08AM	Jim Cramer on IQVIA: "I Like the Business Very Much, I Just Don't Know Whether This Is the Right Stock to Play It" (Insider Monkey)
Mar-03-26 09:33AM	MongoDB downgraded, Block upgraded: Wall Street's top analyst calls (The Fly)
Mar-02-26 04:30PM	IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference (Business Wire)
04:15PM	IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference (Business Wire)
12:13PM	Can AI Acceleration and R&D Strength Drive VEEV Ahead of Q4 Earnings? (Zacks)
Mar-01-26 04:24AM	Analysts at Mizuho Remain Bullish on IQVIA (IQV) Following Q4 Results (Insider Monkey)
Feb-27-26 04:47PM	IQVIA Releases its 2025 Sustainability Report (Business Wire)
Feb-26-26 11:53PM	Is IQVIA Holdings Inc. (IQV) a Buy Post Earnings? (Insider Monkey) +5.39%
09:03AM	IQVIA Holdings (IQV) Rallied on Waning Concerns Over Biotech Funding and Clinical Activity (Insider Monkey)
06:42AM	IQVIA to acquire Charles River drug discovery assets (Pharmaceutical Technology)
Feb-25-26 11:08PM	3 Reasons to Sell IQV and 1 Stock to Buy Instead (StockStory)
09:06AM	Charles River Labs Breaks The Mold, Announces Bold Divestiture Plans (Benzinga)
07:00AM	IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities (Business Wire)
Feb-24-26 02:33PM	IQVIA Holdings Inc. (IQV) Offers Impressive Upside Despite AI-Linked Threats (Insider Monkey)
Feb-21-26 10:39AM	Morgan Stanley Lowers its Price Target on IQVIA Holdings Inc. (IQV) to $240 but Maintains an Overweight Rating (Insider Monkey)
Feb-19-26 10:36AM	TransUnion Stock Gains 6% Post Reporting Q4 Earnings & Revenue Beat (Zacks)
05:38AM	Is Wall Street Bullish or Bearish on IQVIA Holdings Stock? (Barchart)
Feb-18-26 04:15PM	IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day (Business Wire)
09:15AM	Unlocking IQVIA (IQV) International Revenues: Trends, Surprises, and Prospects (Zacks)
Feb-17-26 11:46AM	Waste Connections Stock Slides 7% Since Q4 Earnings Beat Estimates (Zacks)
Feb-13-26 08:32AM	Is the Options Market Predicting a Spike in IQVIA Stock? (Zacks)
Feb-12-26 12:30PM	Insperity Stock Price Decreases 18% After Reporting Loss in Q4 (Zacks)
12:36AM	The Top 5 Analyst Questions From IQVIA's Q4 Earnings Call (StockStory)
Feb-11-26 07:19PM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
Feb-10-26 08:00AM	IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions (Business Wire) -5.30%
Feb-08-26 08:39AM	Gartner, Stellantis, And Novo Nordisk Are Among Top 10 Large Cap Losers Last Week (Feb. 2-Feb. 6): Are the Others in Your Portfolio? (Benzinga)
Feb-06-26 07:21PM	IQVIA Q4 Earnings Call Highlights (MarketBeat)
09:40AM	Why IQVIA Holdings (IQV) is a Top Value Stock for the Long-Term (Zacks)
12:54AM	Analyst Report: IQVIA Holdings Inc. (Morningstar Research)
12:35AM	IQV Q4 Deep Dive: Market Cautions Despite Revenue Beat and AI Strategy Emphasis (StockStory)
Feb-05-26 04:00PM	IQVIA Holdings Inc (IQV) Q4 2025 Earnings Call Highlights: Strong Revenue Growth and Strategic ... (GuruFocus.com) -10.65%
12:11PM	IQVIA Q4 Earnings & Revenues Beat Estimates, Increase Y/Y (Zacks)
11:55AM	IQVIA (IQV) Stock Trades Down, Here Is Why (StockStory)
09:07AM	IQVIA backs AI strategy as analysts question impact on business (Reuters)
08:15AM	IQVIA Holdings (IQV) Q4 Earnings and Revenues Top Estimates (Zacks)
07:36AM	IQVIA's (NYSE:IQV) Q4 CY2025 Sales Top Estimates (StockStory)
07:20AM	IQVIA: Q4 Earnings Snapshot (Associated Press Finance)
07:00AM	IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance (Business Wire)
Feb-04-26 11:40AM	IQV or IDXX: Which Is the Better Value Stock Right Now? (Zacks)
Feb-03-26 10:14PM	IQVIA (IQV) Reports Q4: Everything You Need To Know Ahead Of Earnings (StockStory) -11.88%
11:23AM	IQVIA Set to Report Q4 Earnings: Here's What You Should Know (Zacks)
09:15AM	Unlocking Q4 Potential of IQVIA (IQV): Exploring Wall Street Estimates for Key Metrics (Zacks)
Jan-29-26 08:00AM	IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration (Business Wire)
Jan-25-26 11:44AM	Beyond Biotech-3 Healthcare Stocks for Growth-Minded Investors (MarketBeat)
Jan-22-26 04:05PM	IQVIA Named to the Fortune Worlds Most Admired Companies List, Ranked No. 1 in Its Sector for Fifth Consecutive Year (Business Wire)
Jan-20-26 04:45PM	IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026 (Business Wire)
Jan-15-26 09:36AM	3 Medical Device Companies in Focus for Monetizing Data and Analytics (Zacks)
Jan-14-26 09:50AM	Why IQVIA Holdings (IQV) is a Top Momentum Stock for the Long-Term (Zacks)
Jan-13-26 09:11AM	What You Need To Know Ahead of IQVIAs Earnings Release (Barchart)
Jan-12-26 11:36PM	2 Large-Cap Stocks Worth Your Attention and 1 We Turn Down (StockStory)

Show Previous News

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Berkshire James G.	See Remarks	Sep 02 '26	Option Exercise	131.82	5,381	709,323	13,558	Sep 04 05:00 PM
Berkshire James G.	See Remarks	Sep 02 '26	Sale	261.33	2,668	697,228	10,890	Sep 04 05:00 PM
JAMES G BERKSHIRE	Officer	Sep 02 '26	Proposed Sale	261.32	2,668	697,215		Sep 02 04:11 PM
STAUB W RICHARD	See Remarks	Aug 03 '26	Sale	232.68	5,500	1,279,740	13,312	Aug 04 05:00 PM
Patel Bhavik	See Remarks	Jul 31 '26	Sale	235.27	1,855	436,426	1,348	Aug 04 05:00 PM
WALTER STAUB	Officer	Aug 03 '26	Proposed Sale	232.68	5,500	1,279,740		Aug 03 04:14 PM
Sherbet Eric	See Remarks	Jul 29 '26	Sale	249.16	5,000	1,245,800	20,999	Jul 31 05:04 PM
Cherofsky Keriann	See Remarks	Jul 29 '26	Sale	245.21	558	136,827	2,989	Jul 31 05:03 PM
BOUSBIB ARI	See Remarks	Jul 29 '26	Option Exercise	78.21	156,206	12,216,871	992,147	Jul 31 05:02 PM
BOUSBIB ARI	See Remarks	Jul 29 '26	Sale	245.51	106,279	26,092,072	885,868	Jul 31 05:02 PM
BHAVIK PATEL	Officer	Jul 31 '26	Proposed Sale	235.27	1,855	436,426		Jul 31 04:04 PM
KERIANN CHEROFSKY	Officer	Jul 29 '26	Proposed Sale	245.21	558	136,827		Jul 29 04:10 PM
ERIC SHERBET	Officer	Jul 29 '26	Proposed Sale	249.16	5,000	1,245,775		Jul 29 04:07 PM
ARI BOUSBIB	Officer	Jul 29 '26	Proposed Sale	245.50	106,279	26,091,897		Jul 29 04:04 PM
BOUSBIB ARI	See Remarks	Dec 18 '25	Option Exercise	59.90	50,000	2,995,000	857,163	Dec 19 05:00 PM
BOUSBIB ARI	See Remarks	Dec 18 '25	Sale	222.43	36,564	8,132,931	820,599	Dec 19 05:00 PM
ARI BOUSBIB	Officer	Dec 18 '25	Proposed Sale	222.43	36,564	8,132,876		Dec 18 05:41 PM

IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. It operates through the following segments: Technology and Analytics Solutions, Research and Development Solutions, and Contract Sales and Medical Solutions. The Technology and Analytics Solutions segment supplies mission-critical information, technology solutions, and real-world evidence services to the company's life sciences clients. The Research and Development Solutions segment provides outsourced clinical research and clinical trial-related services. The Contract Sales and Medical Solutions segment offers healthcare provider and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company was founded by Dennis B. Gillings and Gary Koch in 1950 and is headquartered in Durham, NC.

CEO & ChairmanMr. Ari Bousbib

Executive VPMr. Eric M. Sherbet J.D.

President of Research & Development SolutionsMr. W. Richard Staub III

President of Commercial SolutionsMr. Alistair Grenfell

Executive VP & Chief Financial OfficerMr. Michael J. Fedock MBA

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

IQV

IQVIA Holdings Inc

Upgrade your Finviz experience